NewsRx

Search our medical news database

Ikano Therapeutics Inc.

ITI Appoints Patrick Fabbio Chief Financial Officer

Published in Gastroenterology Week, May 25th, 2009

Ikano Therapeutics Inc. (ITI) announced that Patrick Fabbio has joined the Company as Chief Financial Officer. Mr. Fabbio previously held senior financial, transactional and operational positions with sanofi-aventis, where he most recently served as Senior Director, US Life Cycle Management & Base Business.

Peter Young, Chief Executive Officer of ITI, commented, “Pat is an ideal fit for ITI. His broad and diversified background spans the financial and business development functions across the perspective of both large and small pharmaceutical companies. As CFO at ITI, he will have key responsibilities in both of these important functional areas -- especially as we seek...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gastroenterology Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook